Full-thickness chest wall reconstruction using autologous tissue grafts after resection of recurrent desmoid tumor

The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi
Katsuyuki AsaiTeruhisa Kazui

Abstract

We report the case of a 62-year-old woman with a recurrent desmoid tumor of the chest wall who successfully underwent a full-thickness chest wall resection as well as skeletal and soft tissue reconstruction. In chest wall reconstruction, we used various kinds of autologous tissue grafts, i.e. rib, fascia lata and the transverse rectus abdominis myocutaneous flap. Judging from the reconstructed wall's strength, shape and flexibility, as well as wound healing, it is possible to conclude that this combined procedure is feasible because benefits of the procedure outweigh the disadvantage of additional operations for harvests.

References

Aug 18, 1999·Seminars in Thoracic and Cardiovascular Surgery·P J Allen, C D Shriver
Nov 11, 1999·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·B TunçözgürH Akay
Jul 18, 2002·The Annals of Thoracic Surgery·Kazuya SuzukiTeruhisa Kazui
May 2, 2003·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Katsuyuki AsaiYusuke Kita

❮ Previous
Next ❯

Citations

Jul 9, 2008·General Thoracic and Cardiovascular Surgery·Katsushi YamashitaAbul Hasan Muhammad Bashar
Dec 24, 2010·Orvosi hetilap·Zoltán MátraiMiklós Kásler
Dec 11, 2007·General Thoracic and Cardiovascular Surgery·Katsushi YamashitaMuhammad Bashar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.